Tuesday, November 11
9:00 am Workshop Check-In & Networking
9:30 am Expanding TIL Therapies Beyond Melanoma: Overcoming Biological and Manufacturing Barriers
Synopsis
As TIL therapies move beyond melanoma into more complex tumor types, new biological and manufacturing challenges emerge. This session explores the interplay between tumor biology, starting material quality, and therapeutic end-points, highlighting strategies to enhance efficacy across diverse indications.
12:30 pm Networking Break
1:30 pm Overcoming Scale-Up Challenges to Ensure Preparation for Commercial Scale
Synopsis
This session explores how artificial intelligence is transforming both the analytical and operational aspects of TIL therapy development. From designing clinically meaningful potency assays to navigating the complexities of scaling up manufacturing, experts will share insights on leveraging AI to accelerate progress and ensure commercial readiness.